Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:3039
doi: 10.1161/CIRCULATIONAHA.107.183532
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

(Circulation. 2007;115:3039.)
© 2007 American Heart Association, Inc.

Issue Highlights


*    LONG-TERM PROGNOSTIC VALUE OF NEOPTERIN: A NOVEL MARKER OF MONOCYTE ACTIVATION IN PATIENTS WITH ACUTE CORONARY SYNDROME, by Ray et al.
up arrowTop
*LONG-TERM PROGNOSTIC VALUE OF...
down arrowSUPERIOR CARDIOVASCULAR EFFECT...
down arrowEXERCISE TRAINING NORMALIZES...
down arrowRANDOMIZED TRIAL OF ACUPUNCTURE...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Inflammatory processes are major contributors to atherothrombosis. As such, investigators have maintained intense interest in identifying noninvasive tools to detect underlying inflammation that may (1) enhance risk assessment, (2) direct specific interventions to modify risk, and (3) provide a means by which to monitor the response to therapy. Neopterin, a soluble biomarker produced by activated monocytes, has shown promise as a prognostic indicator in small clinical studies of patients with acute coronary syndromes. Ray and colleagues assessed the association between neopterin and clinical outcomes in {approx}4000 patients with ACS and showed an adjusted 86% higher relative risk of death in patients with a neopterin concentration in the highest quartile (≥12.11 nmol/L). Intensive statin therapy significantly attenuated the risk associated with an elevated baseline concentration of neopterin. These findings support continued investigation of neopterin as a potential tool to target and monitor the success of preventive therapies with antiinflammatory actions. See p 3071.


*    SUPERIOR CARDIOVASCULAR EFFECT OF AEROBIC INTERVAL TRAINING VERSUS MODERATE CONTINUOUS TRAINING IN HEART FAILURE PATIENTS: A RANDOMIZED STUDY, by Wisløff et al.
up arrowTop
up arrowLONG-TERM PROGNOSTIC VALUE OF...
*SUPERIOR CARDIOVASCULAR EFFECT...
down arrowEXERCISE TRAINING NORMALIZES...
down arrowRANDOMIZED TRIAL OF ACUPUNCTURE...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
and


*    EXERCISE TRAINING NORMALIZES SYMPATHETIC OUTFLOW BY CENTRAL ANTIOXIDANT MECHANISMS IN RABBITS WITH PACING-INDUCED CHRONIC HEART FAILURE, by Gao et al.
up arrowTop
up arrowLONG-TERM PROGNOSTIC VALUE OF...
up arrowSUPERIOR CARDIOVASCULAR EFFECT...
*EXERCISE TRAINING NORMALIZES...
down arrowRANDOMIZED TRIAL OF ACUPUNCTURE...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Exercise training among patients with heart failure has been shown to have beneficial effects beyond improvements in exercise capacity. The mechanisms by which these favorable effects occur are not yet fully understood, and the optimal training regimen that should be prescribed to attain these benefits is not known. In this issue of Circulation, 2 related papers are presented. Gao and colleagues report interesting findings from study of a rabbit model used to evaluate whether the observed favorable alterations in sympathoexcitation are attributable to antioxidative changes that occur in the central nervous system. In a clinical study of patients with heart failure, Wisløff et al evaluated whether differences in exercise training intensity (high-intensity interval exercise versus moderate-intensity continuous exercise) yield discrete changes in antioxidant status, left ventricular remodeling, and vascular function. The provocative findings of these important studies are discussed in an accompanying editorial by Belardinelli. See pp 3086 and 3095 (editorial p 3042).


*    RANDOMIZED TRIAL OF ACUPUNCTURE TO LOWER BLOOD PRESSURE, by Flachskampf et al.
up arrowTop
up arrowLONG-TERM PROGNOSTIC VALUE OF...
up arrowSUPERIOR CARDIOVASCULAR EFFECT...
up arrowEXERCISE TRAINING NORMALIZES...
*RANDOMIZED TRIAL OF ACUPUNCTURE...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
East meets West in this single blinded trial of 160 patients with hypertension randomized to active or sham acupuncture treatments. The treatments were conducted by highly trained Chinese physicians in 22 sessions over a 6-week period. At the first follow-up visit, the group allocated to the active arm had lower 24-hour ambulatory blood pressure relative to the sham treatment group. This difference in blood pressure was not sustained, however, at subsequent evaluations. Although this trial cannot be considered as definitive, it represents a strong attempt to use modern clinical trial methodology to probe ancient medicine. See p 3121 (editorial p 3048).

Visit http://circ.ahajournals.org:


*    Cardiology Patient Page
up arrowTop
up arrowLONG-TERM PROGNOSTIC VALUE OF...
up arrowSUPERIOR CARDIOVASCULAR EFFECT...
up arrowEXERCISE TRAINING NORMALIZES...
up arrowRANDOMIZED TRIAL OF ACUPUNCTURE...
*Cardiology Patient Page
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Testing in the Noninvasive Vascular Laboratory. See p e624.


*    Images in Cardiovascular Medicine
up arrowTop
up arrowLONG-TERM PROGNOSTIC VALUE OF...
up arrowSUPERIOR CARDIOVASCULAR EFFECT...
up arrowEXERCISE TRAINING NORMALIZES...
up arrowRANDOMIZED TRIAL OF ACUPUNCTURE...
up arrowCardiology Patient Page
*Images in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Diagnostic Utility of Cardiac Magnetic Resonance Imaging in Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Pattern of Left Ventricular Hypertrophy. See p e627.


Figure 15064
View larger version (62K):
[in this window]
[in a new window]

 

Percutaneous Retrieval of a Lost Guidewire That Caused Cardiac Tamponade. See p e629.

Pulmonary Artery Thrombosis and Hemoptysis in Eisenmenger Syndrome. See p e632.


*    Book Review
up arrowTop
up arrowLONG-TERM PROGNOSTIC VALUE OF...
up arrowSUPERIOR CARDIOVASCULAR EFFECT...
up arrowEXERCISE TRAINING NORMALIZES...
up arrowRANDOMIZED TRIAL OF ACUPUNCTURE...
up arrowCardiology Patient Page
up arrowImages in Cardiovascular...
*Book Review
down arrowCorrespondence
 
Heart Valve Disease: A Guide to Patient Management After Surgery. See p e635.


*    Correspondence
up arrowTop
up arrowLONG-TERM PROGNOSTIC VALUE OF...
up arrowSUPERIOR CARDIOVASCULAR EFFECT...
up arrowEXERCISE TRAINING NORMALIZES...
up arrowRANDOMIZED TRIAL OF ACUPUNCTURE...
up arrowCardiology Patient Page
up arrowImages in Cardiovascular...
up arrowBook Review
*Correspondence
 
See p e637.





This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content